Unknown

Dataset Information

Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.


ABSTRACT:

Background

It is argued that, the efficacy of anti-malarials could be prolonged through policy-mediated reductions in drug pressure, but gathering evidence of the relationship between policy, treatment practice, drug pressure and the evolution of resistance in the field is challenging. Mathematical models indicate that drug coverage is the primary determinant of drug pressure and the driving force behind the evolution of drug resistance. These models show that where the basis of resistance is multigenic, the effects of selection can be moderated by high recombination rates, which disrupt the associations between co-selected resistance genes.

Methods

To test these predictions, dhfr and dhps frequency changes were measured during 2000-2001 while SP was the second-line treatmen

SUBMITTER: Malisa AL 

PROVIDER: S-EPMC2908640 | biostudies-literature | 2010 Jul

REPOSITORIES: biostudies-literature